Tag Archives: Jack Meehan
Myriad Genetics (MYGN) Receives a Sell from Barclays
In a report released yesterday, Jack Meehan from Barclays maintained a Sell rating on Myriad Genetics (MYGN – Research Report), with a price target of $22. The company’s shares closed last Monday at $22.97, close to its 52-week low of
Analysts Have Conflicting Sentiments on These Conglomerates Companies: Avantor Inc (NYSE: AVTR) and Lear Corp (NYSE: LEA)
Companies in the Conglomerates sector have received a lot of coverage today as analysts weigh in on Avantor Inc (AVTR – Research Report) and Lear Corp (LEA – Research Report). Avantor Inc (AVTR) Barclays analyst Jack Meehan maintained a Buy
Barclays Maintains Their Hold Rating on Bruker Corp (BRKR)
In a report issued on June 21, Jack Meehan from Barclays maintained a Hold rating on Bruker Corp (BRKR – Research Report), with a price target of $44. The company’s shares closed on Friday at $48.76, close to its 52-week
Analysts’ Opinions Are Mixed on These Conglomerates Stocks: Mettler-Toledo (NYSE: MTD), Magna International (NYSE: MGA) and Kornit Digital (NASDAQ: KRNT)
Analysts have been eager to weigh in on the Conglomerates sector with new ratings on Mettler-Toledo (MTD – Research Report), Magna International (MGA – Research Report) and Kornit Digital (KRNT – Research Report). Mettler-Toledo (MTD) In a report issued on
Icon plc (ICLR) Receives a Hold from Barclays
Barclays analyst Jack Meehan maintained a Hold rating on Icon plc (ICLR – Research Report) yesterday and set a price target of $154. The company’s shares closed yesterday at $133.19. According to TipRanks.com, Meehan is a 4-star analyst with an
Thermo Fisher (TMO) Received its Third Buy in a Row
After Deutsche Bank and UBS gave Thermo Fisher (NYSE: TMO) a Buy rating last month, the company received another Buy, this time from Barclays. Analyst Jack Meehan maintained a Buy rating on Thermo Fisher yesterday and set a price target
